Non-operative therapies for colorectal liver metastases

scientific article published on April 2015

Non-operative therapies for colorectal liver metastases is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.3978/J.ISSN.2078-6891.2014.065
P932PMC publication ID4311101
P698PubMed publication ID25830041
P5875ResearchGate publication ID274401289

P2093author name stringSalma K Jabbour
Akshar N Patel
Inaya Ahmed
John L Nosher
Rebecca Moss
Philip G Murillo
Vyacheslav Gendel
P2860cites workQuality of life after stereotactic body radiation therapy for primary and metastatic liver tumorsQ33305397
Phase I study of individualized stereotactic body radiotherapy of liver metastases.Q33383521
Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapyQ33385648
Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literatureQ33502056
Ablative therapies for colorectal liver metastases: a systematic reviewQ33937325
Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastasesQ34059726
Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysisQ34429210
Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer.Q34658519
Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overviewQ35832101
Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole liversQ35979752
Hepatic tumor ablation with clustered microwave antennae: the US Phase II trialQ36063466
Microwave ablation: principles and applications.Q36287678
Intrahepatic tumor recurrence after partial hepatectomy: value of percutaneous radiofrequency ablationQ36631312
First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI).Q36642970
Drug-eluting particles for interventional pharmacology.Q37197739
Yttrium-90 radioembolization as salvage therapy for colorectal cancer with liver metastasesQ37339616
Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective studyQ37353563
Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumorsQ37373799
Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An updateQ37391183
Chemotherapy with targeted agents for the treatment of metastatic colorectal cancerQ37467967
Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastasesQ83412928
Matched-pair comparison of radioembolization plus best supportive care versus best supportive care alone for chemotherapy refractory liver-dominant colorectal metastasesQ84617827
Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcoholQ85010584
Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experienceQ37587013
Radiotherapy for liver metastases: a review of evidenceQ37979325
Current status of embolic agents for liver tumor embolizationQ38027067
Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-upQ38054681
Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic reviewQ38124073
Intra-arterial therapies for metastatic colorectal cancerQ38179343
Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III studyQ39630468
Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study.Q40301411
Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trialQ40649086
Cryosurgical ablation of hepatic colorectal metastases.Q42638641
Irreversible electroporation for treatment of liver cancer.Q42781041
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapyQ43010373
Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary resultsQ44426543
Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patientsQ44441242
Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma: how many are too many?Q44519652
Percutaneous microwave coagulation therapy for solitary metastatic liver tumors from colorectal cancer: a pilot clinical studyQ44637547
Radioembolization and systemic chemotherapy improves response and survival for unresectable colorectal liver metastasesQ44794355
Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignanciesQ45055043
Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancerQ45119871
Hepatic arterial infusion after liver resectionQ45270082
Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation.Q46011640
Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysisQ46159777
Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trialQ47862162
Liver disease induced by radioembolization of liver tumors: description and possible risk factorsQ47925759
Radio-frequency ablation of colorectal liver metastases in 167 patientsQ48820048
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastasesQ49186620
Selective internal radiation therapy with SIR-spheres for the treatment of unresectable colorectal hepatic metastasesQ50153921
Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.Q51043928
Radiofrequency ablation permits an effective treatment for colorectal liver metastasis.Q51093391
Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience.Q51204089
Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".Q51296233
Hepatic radiofrequency ablation.Q51722096
Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.Q51840650
Chemotherapy and regional therapy of hepatic colorectal metastases: expert consensus statement.Q52930698
Microwave ablation for unresectable hepatic tumours: clinical results using a novel microwave probe and generator.Q53326350
Phase II study on stereotactic body radiotherapy of colorectal metastases.Q53687868
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: prespecified subgroup analyses from the VELOUR trial.Q54401988
Stereotactic High Dose Fraction Radiation Therapy of Extracranial Tumors Using An Accelerator: Clinical experience of the first thirty-one patientsQ71783537
Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinomaQ74081538
Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patientsQ74543135
Prognostic factors after cryotherapy for hepatic metastases from colorectal cancerQ77125611
Radiofrequency ablation for unresectable hepatic tumorsQ77625958
Prognostic Factors for Percutaneous Microwave Coagulation Therapy of Hepatic MetastasesQ79196755
Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastasesQ79465276
Cryosurgery for resectable and unresectable hepatic metastases from colorectal cancerQ79829253
Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first- and second-line managementQ80152879
Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastasesQ81124780
Radiofrequency-ablation of unresectable primary and secondary liver tumors: results in 88 patientsQ83129757
P433issue2
P304page(s)224-240
P577publication date2015-04-01
P1433published inJournal of gastrointestinal oncologyQ26842467
P1476titleNon-operative therapies for colorectal liver metastases
P478volume6

Reverse relations

cites work (P2860)
Q90443973Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018)
Q37744386Panax ginseng Meyer prevents radiation-induced liver injury via modulation of oxidative stress and apoptosis
Q90664385Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors

Search more.